Barenie RE - Search Results

1

"I Think Deprescribing as a Whole Is a Gap!": A Qualitative Study of Student Pharmacist Perceptions about Deprescribing.

Springer SP, Cernasev A, Barenie RE, Axon DR, Scott D. Springer SP, et al. Among authors: barenie re. Geriatrics (Basel). 2022 Jun 2;7(3):60. doi: 10.3390/geriatrics7030060. Geriatrics (Basel). 2022. PMID: 35735765 Free PMC article.

2

Accuracy of publicly-listed locator information for buprenorphine waivered practitioners and opioid treatment programs in the US, 2020.

Barenie RE, Winbigler BL, Heidel RE, Wheeler JS. Barenie RE, et al. Subst Abus. 2022;43(1):999-1003. doi: 10.1080/08897077.2022.2060430. Subst Abus. 2022. PMID: 35435809

3

Healthcare Professional Students' Perspectives on Substance Use Disorders and Stigma: A Qualitative Study.

Cernasev A, Kline KM, Barenie RE, Hohmeier KC, Stewart S, Forrest-Bank SS. Cernasev A, et al. Among authors: barenie re. Int J Environ Res Public Health. 2022 Feb 27;19(5):2776. doi: 10.3390/ijerph19052776. Int J Environ Res Public Health. 2022. PMID: 35270468 Free PMC article.

4

The Academy Is Well Positioned to Offer Pharmacy Technician Training Programs.

Barenie RE, Wheeler JS. Barenie RE, et al. Am J Pharm Educ. 2022 Feb;86(2):ajpe8554. doi: 10.5688/ajpe8554. Epub 2021 May 11. Am J Pharm Educ. 2022. PMID: 35228199 Free PMC article.

5

A social media microinfluencer intervention to reduce coronavirus disease 2019 vaccine hesitancy in underserved Tennessee communities: A protocol paper.

Hohmeier KC, Barenie RE, Hagemann TM, Renfro C, Xing K, Phillips A, Allen R, Fiscus MD, Chisholm-Burns M, Gatwood J. Hohmeier KC, et al. Among authors: barenie re. J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):326-334. doi: 10.1016/j.japh.2021.11.028. Epub 2021 Nov 26. J Am Pharm Assoc (2003). 2022. PMID: 34893443 Free PMC article.

6

Evaluating the Pre-Multistate Pharmacy Jurisprudence Exam and Other Factors Associated with Performance on the Multistate Pharmacy Jurisprudence Exam.

Havrda DE, Hall EA, Spivey CA, Biliter LT, Barenie RE, Chisholm-Burns MA. Havrda DE, et al. Among authors: barenie re. Am J Pharm Educ. 2021 Nov 16:8774. doi: 10.5688/ajpe8774. Online ahead of print. Am J Pharm Educ. 2021. PMID: 34785499

7

Public funding and the importance of reasonable pricing for buprenorphine.

Barenie RE, Kesselheim AS. Barenie RE, et al. Drug Alcohol Depend. 2021 Apr 1;221:108643. doi: 10.1016/j.drugalcdep.2021.108643. Epub 2021 Feb 20. Drug Alcohol Depend. 2021. PMID: 33642093 No abstract available.

8

Associations Between Copays, Coverage Limits for Opioid Use Disorder Medications, and Prescribing in Medicaid, 2018.

Barenie RE, Kesselheim AS, Tsacogianis T, Fischer MA. Barenie RE, et al. Med Care. 2021 Mar 1;59(3):266-272. doi: 10.1097/MLR.0000000000001494. Med Care. 2021. PMID: 33560766

9

Factors Affecting Buprenorphine Utilization and Spending in Medicaid, 2002-2018.

Barenie RE, Sinha MS, Kesselheim AS. Barenie RE, et al. Value Health. 2021 Feb;24(2):182-187. doi: 10.1016/j.jval.2020.04.1840. Epub 2020 Oct 21. Value Health. 2021. PMID: 33518024 Free article.

10

Buprenorphine for opioid use disorder: The role of public funding in its development.

Barenie RE, Kesselheim AS. Barenie RE, et al. Drug Alcohol Depend. 2021 Feb 1;219:108491. doi: 10.1016/j.drugalcdep.2020.108491. Epub 2020 Dec 21. Drug Alcohol Depend. 2021. PMID: 33421798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results